查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726135

經導管栓塞和阻塞設備市場規模、佔有率、趨勢分析報告：2025 年至 2030 年按產品、地區和細分市場預測

Transcatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report By Product (Coil, Non-coil),By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 210 Pages | 商品交期: 2-10個工作天內

價格

經導管栓塞和閉塞 (TEO) 設備市場的成長和趨勢

根據 Grand View Research, Inc. 的最新報告，全球經導管栓塞和阻塞設備市場預計到 2030 年將達到 85.4 億美元，2025 年至 2030 年期間的複合年成長率為 7.7%。

TEO 設備市場的主要促進因素包括微創手術的採用率不斷提高和癌症盛行率不斷上升。

此外，栓塞術廣泛用於治療非癌症疾病（例如血管畸形和纖維化），正在推動全球對 TEO 設備的需求。此外，技術先進、效率更高的產品的推出也支持了全球市場的成長。然而，高成本、嚴格的監管核准程序以及需要經驗豐富的醫療專業人員來執行 TEO 手術等因素可能會對其發展產生負面影響。

由於醫療保健支出的增加和醫療保健基礎設施的改善，亞太地區 TEO 設備市場預計將以最高的複合年成長率成長。亞太新興國家醫療旅遊業的快速擴張也推動了對 TEO 設備的需求。

經導管栓塞及阻塞設備市場報告重點

  • 2024 年，非線圈產品領域佔據市場主導地位，收益佔有率最大，為 52.3%，這得益於其在廣泛臨床應用中的多功能性和有效性。
  • 由於線圈產品在各種血管疾病治療的應用不斷擴大，預計預測期內線圈產品部門的複合年成長率將達到 7.0%。
  • 由於介入放射學 (IR) 程序的採用率不斷提高，北美在 2024 年佔據全球市場主導地位，收益佔有率最高，為 36.6%。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 經導管栓塞和阻塞設備市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 經導管栓塞及阻塞設備市場分析工具
    • 產業分析—波特五力分析
    • PESTLE分析

第4章。經導管栓塞和阻塞設備市場：按產品進行的估計和趨勢分析

  • 產品細分儀表板
  • 經導管栓塞及阻塞設備市場：產品差異分析
  • 全球經導管栓塞及阻塞設備市場規模及趨勢分析（依產品，2018-2030）
  • 線圈
    • 可推線圈
    • 可拆卸線圈
  • 無線圈
    • 導流裝置
    • 栓塞顆粒
    • 液體栓子
    • 其他栓塞及阻塞設備
    • 配件

5. 經導管栓塞和阻塞設備市場：區域、估計和趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 經導管栓塞及阻塞設備市場（按地區）: 關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024 年重點公司熱圖分析
  • 公司簡介
    • Boston Scientific Corporation
    • Terumo Corporation
    • Medtronic
    • DePuy Synthes（Johnson & Johnson）
    • Stryker
    • Cordis
    • Abbott
    • Pfizer Inc.
    • Sirtex SIR-Spheres Pty Ltd.
    • 諾迪恩（加拿大）公司
Product Code: 978-1-68038-670-7

Transcatheter Embolization And Occlusion Devices Market Growth & Trends:

The global transcatheter embolization and occlusion devices market size is estimated to reach USD 8.54 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.

In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.

Asia Pacific TEO devices market is anticipated to witness highest CAGR, due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices.

Transcatheter Embolization And Occlusion Devices Market Report Highlights:

  • In 2024, The non-coil product segment dominated the market with the largest revenue share of 52.3%, propelled by its versatility and effectiveness in a wide range of clinical applications.
  • Based product, the coil segment is anticipated to grow at a significant CAGR of 7.0% over the forecast period, driven by its growing application in treating various vascular conditions.
  • North America dominated the global market with the largest revenue share of 36.6% in 2024, attributed to the increased adoption of Interventional Radiology (IR) procedures.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional Scope
    • 1.2.3. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Embolization and Occlusion Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Transcatheter Embolization and Occlusion Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Transcatheter Embolization and Occlusion Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
  • 4.3. Global Transcatheter Embolization and Occlusion Devices Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Coil
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Pushable Coils
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Detachable Coils
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Non Coil
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Flow Diverting Devices
      • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Embolization Particles
      • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Liquid Embolics
      • 4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Other Embolization and Occlusion Devices
      • 4.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Accessories
      • 4.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Transcatheter Embolization and Occlusion Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Transcatheter Embolization and Occlusion Devices Market by Region: Key Takeaways
  • 5.4. North America
    • 5.4.1. U.S.
      • 5.4.1.1. Key Country Dynamics
      • 5.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.1.3. Competitive Scenario
      • 5.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Canada
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.2.3. Competitive Scenario
      • 5.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Mexico
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.3.3. Competitive Scenario
      • 5.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. U.K.
      • 5.5.1.1. Key Country Dynamics
      • 5.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.1.3. Competitive Scenario
      • 5.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. France
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Italy
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Spain
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.5.3. Competitive Scenario
      • 5.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Denmark
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.6.3. Competitive Scenario
      • 5.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.7.3. Competitive Scenario
      • 5.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.8. Norway
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.8.3. Competitive Scenario
      • 5.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. China
      • 5.6.1.1. Key Country Dynamics
      • 5.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.1.3. Competitive Scenario
      • 5.6.1.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.3. India
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.4. South Korea
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Australia
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Thailand
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.7.2.3. Competitive Scenario
      • 5.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.7.3.3. Competitive Scenario
      • 5.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Middle East and Africa
    • 5.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.2.3. Competitive Scenario
      • 5.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.3.3. Competitive Scenario
      • 5.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.4.3. Competitive Scenario
      • 5.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.5.3. Competitive Scenario
      • 5.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/ Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key Company Heat Map Analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Boston Scientific Corporation
      • 6.4.1.1. Company Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. Terumo Corporation
      • 6.4.2.1. Company Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Medtronic
      • 6.4.3.1. Company Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. DePuy Synthes (Johnson & Johnson)
      • 6.4.4.1. Company Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Stryker
      • 6.4.5.1. Company Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Cordis
      • 6.4.6.1. Company Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Abbott
      • 6.4.7.1. Company Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Pfizer Inc.
      • 6.4.8.1. Company Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Sirtex SIR-Spheres Pty Ltd.
      • 6.4.9.1. Company Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Nordion (Canada) Inc.
      • 6.4.10.1. Company Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Transcatheter Embolization and Occlusion Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 5. North America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 6. North America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 7. U.S. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8. Canada Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 9. Mexico Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 10. Europe Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 11. Europe Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 12. U.K. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13. Germany Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 14. France Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15. Italy Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 16. Spain Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 17. Denmark Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 18. Sweden Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19. Norway Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 20. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 21. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 22. China Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23. Japan Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 24. India Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 25. South Korea Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 26. Australia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27. Thailand Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 28. Latin America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 29. Latin America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 30. Brazil Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 31. Argentina Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 34. South Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 35. Saudi Arabia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 36. UAE Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 37. Kuwait Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Transcatheter Embolization and Occlusion Devices Market: Market Outlook
  • Fig. 10 Transcatheter Embolization and Occlusion Devices Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Transcatheter Embolization and Occlusion Devices Market Driver Impact
  • Fig. 16 Transcatheter Embolization and Occlusion Devices Market Restraint Impact
  • Fig. 17 Transcatheter Embolization and Occlusion Devices Market Strategic Initiatives Analysis
  • Fig. 18 Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
  • Fig. 19 Transcatheter Embolization and Occlusion Devices Market: Product Outlook and Key Takeaways
  • Fig. 20 Coil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Pushable Coils Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Detachable Coils Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Non Coil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Flow Diverting Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Embolization Particles Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid Embolics Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Other Embolization and Occlusion Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Accessories Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Global Transcatheter Embolization and Occlusion Devices Market: Regional Movement Analysis
  • Fig. 30 Global Transcatheter Embolization and Occlusion Devices Market: Regional Outlook and Key Takeaways
  • Fig. 31 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Kuwait Market Estimates and Forecasts, 2018 - 2030